Roble, Belko & Company, Inc Abbott Laboratories Transaction History

Roble, Belko & Company, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$100.78 - $112.29 $3,426 - $3,817	-34 Reduced 89.47%	4 $0
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $14,902 - $18,012	-146 Reduced 79.35%	38 $4,000
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $17,103 - $20,856	150 Added 441.18%	184 $22,000
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $3,115 - $3,783	34 New	34 $4,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

Stay updated on Roble, Belko & Company, Inc with notifications on news.